Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 45,124 | 41,961 | 33,062 | 22,117 | 21,711 |
| Cost of Goods | 31,156 | 29,156 | 27,207 | 24,031 | 36,957 |
| Gross Profit | 13,968 | 12,805 | 5,855 | -1,914 | -15,246 |
| Operating Expenses | 22,376 | 23,373 | 23,602 | 26,877 | 27,763 |
| Operating Income | -8,408 | -10,568 | -17,747 | -28,791 | -43,009 |
| Interest Expense | 63 | 576 | 365 | 31 | 10,506 |
| Other Income | 204 | 450 | 4,753 | -1,167 | -1,173 |
| Pre-tax Income | -8,267 | -10,694 | -13,359 | -29,989 | -54,688 |
| Income Tax | N/A | 0 | -276 | -6 | 113 |
| Net Income Continuous | -8,267 | -10,694 | -13,083 | -29,983 | -54,801 |
| Net Income | $-8,267 | $-10,694 | $-13,083 | $-29,983 | $-54,801 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
| EBITDA(a) | $-6,544 | $-7,518 | $-10,478 | $-27,086 | $-38,549 |